share_log

HC Wainwright & Co. Maintains Buy on ORIC Pharmaceuticals, Raises Price Target to $21

HC Wainwright & Co. Maintains Buy on ORIC Pharmaceuticals, Raises Price Target to $21

HC Wainwright & Co.維持對ORIC製藥的買入,將目標股價上調至21美元
Moomoo 24/7 ·  03/21 06:15

HC Wainwright & Co. analyst Robert Burns maintains ORIC Pharmaceuticals (NASDAQ:ORIC) with a Buy and raises the price target from $15 to $21.

HC Wainwright & Co. 分析師羅伯特·伯恩斯維持ORIC Pharmicals(納斯達克股票代碼:ORIC)的買入並將目標股價從15美元上調至21美元。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論